Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

NCT02644044 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT02644044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2018
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

to evaluate the effect of therapy with it mtx on the disease course of patients with progressive ms